Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Aquestive, Astrazeneca, Biogen Eli Lilly, Eisai, Huyabio, In3bio, Merck, Pieris, Roche, Santen, Vectivbio.